{"id":"https://openalex.org/W2115150071","doi":"https://doi.org/10.1053/jhep.2001.23045","title":"Lamivudine Treatment Can Overcome Cytotoxic T\u2013Cell Hyporesponsiveness in Chronic Hepatitis B: New Perspectives for Immune Therapy","display_name":"Lamivudine Treatment Can Overcome Cytotoxic T\u2013Cell Hyporesponsiveness in Chronic Hepatitis B: New Perspectives for Immune Therapy","publication_year":2001,"publication_date":"2001-04-01","ids":{"openalex":"https://openalex.org/W2115150071","doi":"https://doi.org/10.1053/jhep.2001.23045","mag":"2115150071","pmid":"https://pubmed.ncbi.nlm.nih.gov/11283861"},"language":"en","primary_location":{"id":"doi:10.1053/jhep.2001.23045","doi":"https://doi.org/10.1053/jhep.2001.23045","is_oa":true,"landing_page_url":"https://doi.org/10.1053/jhep.2001.23045","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1053/jhep.2001.23045","source":{"id":"https://openalex.org/S156174673","display_name":"Hepatology","issn_l":"0270-9139","issn":["0270-9139","1527-3350"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1053/jhep.2001.23045","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055486206","display_name":"Carolina Boni","orcid":"https://orcid.org/0000-0002-7630-5180","observed_orcids":["https://orcid.org/0000-0002-7630-5180"]},"institutions":[{"id":"https://openalex.org/I124601658","display_name":"University of Parma","ror":"https://ror.org/02k7wn190","country_code":"IT","type":"education","lineage":["https://openalex.org/I124601658"]},{"id":"https://openalex.org/I4210135416","display_name":"Ospedale di Parma","ror":"https://ror.org/03jg24239","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210135416"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Carolina Boni","raw_affiliation_strings":["Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universit\u00e0 di Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universit\u00e0 di Parma, Italy","institution_ids":["https://openalex.org/I124601658","https://openalex.org/I4210135416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031164159","display_name":"Amalia Penna","orcid":"https://orcid.org/0000-0001-9663-1250","observed_orcids":["https://orcid.org/0000-0001-9663-1250"]},"institutions":[{"id":"https://openalex.org/I124601658","display_name":"University of Parma","ror":"https://ror.org/02k7wn190","country_code":"IT","type":"education","lineage":["https://openalex.org/I124601658"]},{"id":"https://openalex.org/I4210135416","display_name":"Ospedale di Parma","ror":"https://ror.org/03jg24239","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210135416"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Amalia Penna","raw_affiliation_strings":["Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universita\u0300 di Parma, Italy","Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universit\u00e0 di Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universita\u0300 di Parma, Italy","institution_ids":["https://openalex.org/I124601658","https://openalex.org/I4210135416"]},{"raw_affiliation_string":"Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universit\u00e0 di Parma, Italy","institution_ids":["https://openalex.org/I124601658","https://openalex.org/I4210135416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050511886","display_name":"Graham Stuart Ogg","orcid":"https://orcid.org/0000-0002-3097-045X","observed_orcids":["https://orcid.org/0000-0002-3097-045X","https://orcid.org/0000-0002-3702-0107"]},"institutions":[{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Graham S. Ogg","raw_affiliation_strings":["Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK","institution_ids":["https://openalex.org/I2802742124","https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039286311","display_name":"Antonio Bertoletti","orcid":"https://orcid.org/0000-0002-2942-0485","observed_orcids":["https://orcid.org/0000-0002-2942-0485"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Antonio Bertoletti","raw_affiliation_strings":["Institute of Hepatology, University College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Hepatology, University College London, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029787958","display_name":"Massimo Pilli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124601658","display_name":"University of Parma","ror":"https://ror.org/02k7wn190","country_code":"IT","type":"education","lineage":["https://openalex.org/I124601658"]},{"id":"https://openalex.org/I4210135416","display_name":"Ospedale di Parma","ror":"https://ror.org/03jg24239","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210135416"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Massimo Pilli","raw_affiliation_strings":["Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universita\u0300 di Parma, Italy","Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universit\u00e0 di Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universita\u0300 di Parma, Italy","institution_ids":["https://openalex.org/I124601658","https://openalex.org/I4210135416"]},{"raw_affiliation_string":"Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universit\u00e0 di Parma, Italy","institution_ids":["https://openalex.org/I124601658","https://openalex.org/I4210135416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070559220","display_name":"Cristina Cavallo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124601658","display_name":"University of Parma","ror":"https://ror.org/02k7wn190","country_code":"IT","type":"education","lineage":["https://openalex.org/I124601658"]},{"id":"https://openalex.org/I4210135416","display_name":"Ospedale di Parma","ror":"https://ror.org/03jg24239","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210135416"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Cristina Cavallo","raw_affiliation_strings":["Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universita\u0300 di Parma, Italy","Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universit\u00e0 di Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universita\u0300 di Parma, Italy","institution_ids":["https://openalex.org/I124601658","https://openalex.org/I4210135416"]},{"raw_affiliation_string":"Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universit\u00e0 di Parma, Italy","institution_ids":["https://openalex.org/I124601658","https://openalex.org/I4210135416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015328811","display_name":"Albertina Cavalli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124601658","display_name":"University of Parma","ror":"https://ror.org/02k7wn190","country_code":"IT","type":"education","lineage":["https://openalex.org/I124601658"]},{"id":"https://openalex.org/I4210135416","display_name":"Ospedale di Parma","ror":"https://ror.org/03jg24239","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210135416"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Albertina Cavalli","raw_affiliation_strings":["Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universita\u0300 di Parma, Italy","Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universit\u00e0 di Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universita\u0300 di Parma, Italy","institution_ids":["https://openalex.org/I124601658","https://openalex.org/I4210135416"]},{"raw_affiliation_string":"Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universit\u00e0 di Parma, Italy","institution_ids":["https://openalex.org/I124601658","https://openalex.org/I4210135416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111472755","display_name":"Simona Urbani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124601658","display_name":"University of Parma","ror":"https://ror.org/02k7wn190","country_code":"IT","type":"education","lineage":["https://openalex.org/I124601658"]},{"id":"https://openalex.org/I4210135416","display_name":"Ospedale di Parma","ror":"https://ror.org/03jg24239","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210135416"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Simona Urbani","raw_affiliation_strings":["Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universita\u0300 di Parma, Italy","Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universit\u00e0 di Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universita\u0300 di Parma, Italy","institution_ids":["https://openalex.org/I124601658","https://openalex.org/I4210135416"]},{"raw_affiliation_string":"Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universit\u00e0 di Parma, Italy","institution_ids":["https://openalex.org/I124601658","https://openalex.org/I4210135416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019423476","display_name":"Richard E. Boehme","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Boehme","raw_affiliation_strings":["GlaxoWellcome, Research Triangle Park, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoWellcome, Research Triangle Park, NC","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072114928","display_name":"Ruggero Panebianco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ruggero Panebianco","raw_affiliation_strings":["GlaxoWellcome, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoWellcome, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109359583","display_name":"Franco Fiaccadori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124601658","display_name":"University of Parma","ror":"https://ror.org/02k7wn190","country_code":"IT","type":"education","lineage":["https://openalex.org/I124601658"]},{"id":"https://openalex.org/I4210135416","display_name":"Ospedale di Parma","ror":"https://ror.org/03jg24239","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210135416"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Franco Fiaccadori","raw_affiliation_strings":["Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universita\u0300 di Parma, Italy","Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universit\u00e0 di Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universita\u0300 di Parma, Italy","institution_ids":["https://openalex.org/I124601658","https://openalex.org/I4210135416"]},{"raw_affiliation_string":"Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universit\u00e0 di Parma, Italy","institution_ids":["https://openalex.org/I124601658","https://openalex.org/I4210135416"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070463166","display_name":"Carlo I. Ferrari","orcid":"https://orcid.org/0000-0002-5461-6842","observed_orcids":["https://orcid.org/0000-0002-5461-6842"]},"institutions":[{"id":"https://openalex.org/I124601658","display_name":"University of Parma","ror":"https://ror.org/02k7wn190","country_code":"IT","type":"education","lineage":["https://openalex.org/I124601658"]},{"id":"https://openalex.org/I4210135416","display_name":"Ospedale di Parma","ror":"https://ror.org/03jg24239","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210135416"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Carlo Ferrari","raw_affiliation_strings":["Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universita\u0300 di Parma, Italy","Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universit\u00e0 di Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universita\u0300 di Parma, Italy","institution_ids":["https://openalex.org/I124601658","https://openalex.org/I4210135416"]},{"raw_affiliation_string":"Laboratorio di Immunopatologia Virale, Divisione Malattie Infettive, Azienda Ospedaliera di Parma, and Cattedra di Malattie Infettive, Universit\u00e0 di Parma, Italy","institution_ids":["https://openalex.org/I124601658","https://openalex.org/I4210135416"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5070463166"],"corresponding_institution_ids":["https://openalex.org/I124601658","https://openalex.org/I4210135416"],"apc_list":{"value":2900,"currency":"USD","value_usd":2900},"apc_paid":null,"fwci":21.5015,"has_fulltext":true,"cited_by_count":339,"citation_normalized_percentile":{"value":0.99786504,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"33","issue":"4","first_page":"963","last_page":"971"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lamivudine","display_name":"lamivudine","score":0.9599999785423279},{"id":"https://openalex.org/keywords/chronic-hepatitis-b","display_name":"chronic hepatitis B","score":0.9919999837875366},{"id":"https://openalex.org/keywords/hepatitis-b-virus","display_name":"hepatitis B virus","score":0.9120000004768372},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.9660000205039978},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.7519999742507935},{"id":"https://openalex.org/keywords/hla-a2","display_name":"HLA-A2","score":0.8619999885559082},{"id":"https://openalex.org/keywords/hbeag-positive","display_name":"HBeAg-positive","score":0.7850000262260437},{"id":"https://openalex.org/keywords/viral-load","display_name":"viral load","score":0.652999997138977},{"id":"https://openalex.org/keywords/antiviral-therapy","display_name":"antiviral therapy","score":0.8429999947547913},{"id":"https://openalex.org/keywords/immune-reconstitution","display_name":"immune reconstitution","score":0.7350000143051147},{"id":"https://openalex.org/keywords/t-cell-based-immunotherapy","display_name":"T cell-based immunotherapy","score":0.722000002861023},{"id":"https://openalex.org/keywords/viral-persistence","display_name":"viral persistence","score":0.5600000023841858}],"concepts":[{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.8652104139328003},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.8361759185791016},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.6758013963699341},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6427607536315918},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5959732532501221},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.5643986463546753},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5285638570785522},{"id":"https://openalex.org/C2777382497","wikidata":"https://www.wikidata.org/wiki/Q6853","display_name":"Hepatitis B","level":2,"score":0.525139331817627},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.49211782217025757},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4374714493751526},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4313179850578308},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.42317190766334534},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.2929997444152832},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2252296805381775},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.10411497950553894},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006513","descriptor_name":"Hepatitis B e Antigens","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D008137","descriptor_name":"Longitudinal Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D015789","descriptor_name":"HLA-A2 Antigen","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019694","descriptor_name":"Hepatitis B, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019694","descriptor_name":"Hepatitis B, Chronic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D019694","descriptor_name":"Hepatitis B, Chronic","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D019694","descriptor_name":"Hepatitis B, Chronic","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1053/jhep.2001.23045","doi":"https://doi.org/10.1053/jhep.2001.23045","is_oa":true,"landing_page_url":"https://doi.org/10.1053/jhep.2001.23045","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1053/jhep.2001.23045","source":{"id":"https://openalex.org/S156174673","display_name":"Hepatology","issn_l":"0270-9139","issn":["0270-9139","1527-3350"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology","raw_type":"journal-article"},{"id":"pmid:11283861","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11283861","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology (Baltimore, Md.)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1053/jhep.2001.23045","doi":"https://doi.org/10.1053/jhep.2001.23045","is_oa":true,"landing_page_url":"https://doi.org/10.1053/jhep.2001.23045","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1053/jhep.2001.23045","source":{"id":"https://openalex.org/S156174673","display_name":"Hepatology","issn_l":"0270-9139","issn":["0270-9139","1527-3350"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320311016","display_name":"Fondazione Cariparma","ror":"https://ror.org/04fkd7w53"},{"id":"https://openalex.org/F7296444849","display_name":"Ministerio de Universidades","ror":"https://ror.org/03zcny908"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2115150071.pdf","grobid_xml":"https://content.openalex.org/works/W2115150071.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W1580217007","https://openalex.org/W1813446025","https://openalex.org/W1817144267","https://openalex.org/W1829099663","https://openalex.org/W1985262993","https://openalex.org/W1986791390","https://openalex.org/W2039260754","https://openalex.org/W2040894217","https://openalex.org/W2067069532","https://openalex.org/W2068127052","https://openalex.org/W2069030584","https://openalex.org/W2088165891","https://openalex.org/W2100587714","https://openalex.org/W2111359040","https://openalex.org/W2116118057","https://openalex.org/W2129114331","https://openalex.org/W2130457445","https://openalex.org/W2150492554","https://openalex.org/W2155599296","https://openalex.org/W2156110652","https://openalex.org/W2175117246","https://openalex.org/W2237357092","https://openalex.org/W2420678158"],"related_works":["https://openalex.org/W2069030584","https://openalex.org/W1995416928","https://openalex.org/W2096094255","https://openalex.org/W2053746998","https://openalex.org/W2375719165","https://openalex.org/W4243751673","https://openalex.org/W2040534292","https://openalex.org/W2120995800","https://openalex.org/W2087782184","https://openalex.org/W7100562442"],"abstract_inverted_index":{"The":[0],"hepatitis":[1,51,130,191],"B":[2,192],"virus":[3],"(HBV)":[4],"cytotoxic":[5,134],"T":[6,135,150,210],"lymphocyte":[7],"(CTL)":[8],"response":[9,114,224],"in":[10,58,123,146,189],"patients":[11,126],"with":[12,127],"chronic":[13,50,129,190,228],"HBV":[14,229],"infection":[15],"is":[16,29],"generally":[17],"weak":[18],"or":[19,70],"totally":[20],"undetectable.":[21],"This":[22,166,203],"inability":[23],"to":[24,31,72,84,89,200,226],"mount":[25],"protective":[26,222],"CTL":[27,56,98,113,195,198,223],"responses":[28,57,99],"believed":[30],"be":[32,61],"a":[33,221],"crucial":[34],"determinant":[35],"of":[36,46,55,171,177],"viral":[37,86,91,178],"persistence,":[38],"and":[39,88,92,116,148,174],"its":[40],"correction":[41],"represents":[42],"an":[43],"important":[44],"objective":[45],"immune":[47,212],"therapies":[48,213],"for":[49,104],"B.":[52,131],"However,":[53],"amplification":[54],"vivo":[59,155],"may":[60,205],"ineffective":[62],"if":[63],"HBV-specific":[64,112,133],"CD8":[65],"cells":[66],"are":[67],"either":[68],"absent":[69],"nonresponsive":[71],"exogenous":[73,201],"stimulation.":[74,107,202],"In":[75],"this":[76,109],"study,":[77],"we":[78],"asked":[79],"whether":[80],"antiviral":[81],"treatments":[82],"able":[83,225],"inhibit":[85],"replication":[87],"reduce":[90],"antigen":[93],"load":[94,179],"can":[95,193,218],"successfully":[96,219],"reconstitute":[97,220],"creating":[100],"the":[101,111,169,175,207],"appropriate":[102],"conditions":[103],"their":[105],"therapeutic":[106],"For":[108],"purpose,":[110],"before":[115],"during":[117],"lamivudine":[118,164,187,216],"therapy":[119],"was":[120],"studied":[121],"longitudinally":[122],"6":[124],"HLA-A2-positive":[125],"HBeAg+":[128],"Both":[132],"cell":[136,151],"activity":[137],"measured":[138,153],"by":[139,156,163,181],"chromium":[140],"release":[141],"assay":[142],"on":[143],"peptide":[144],"stimulation":[145],"vitro":[147],"CD8+":[149],"frequency":[152],"ex":[154],"HLA-A2/peptide":[157],"tetramer":[158],"staining":[159],"were":[160],"significantly":[161],"augmented":[162],"therapy.":[165,182],"enhancement":[167],"followed":[168],"reconstitution":[170],"CD4":[172],"reactivity":[173],"decline":[176],"induced":[180],"Our":[183],"study":[184],"shows":[185],"that":[186,209],"treatment":[188,217],"restore":[194],"reactivity,":[196],"making":[197],"susceptible":[199],"effect":[204],"enhance":[206],"probability":[208],"cell-based":[211],"delivered":[214],"after":[215],"cure":[227],"infection.":[230]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":19},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":15}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}